AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Macaulay Capital Plc

Remuneration Information Apr 29, 2024

6067_rns_2024-04-29_8b27363b-ef39-4a53-b4a8-7c14de40481e.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 2884M

Macaulay Capital PLC

29 April 2024

Macaulay Capital PLC

29 April 2024  

Macaulay Capital PLC

("Macaulay Capital" or the "Company")

Grant of share options

Macaulay Capital PLC (AQSE:MCAP), which was formed to originate and manage corporate transactions, raise funds from third parties, invest its own funds alongside those of external investors and to manage its investment portfolio with the aim of maximising its value, announces that it has granted a total of 1,000,000 options over ordinary shares of 10p each in the Company ("Ordinary Shares", "Options") to certain Directors and senior executives of the Company.

The Company's admission document published in July 2022 stated that the Company may award share options to directors, employees and consultants (other than David Horner) and that any awards would be subject to vesting and/or performance conditions, and that the proportion of Ordinary Shares which would be subject to share options would not exceed 20 per cent.

The Options granted do not vest for two years (except in certain exceptional circumstances) and exercise is also subject to a number of performance conditions.  The exercise price of the Options is 21.5p, being the mid-market price at the close of business on 26 April 2024, being the business day before the date of grant.  The Options represent 10 per cent. of the Company's issued share capital.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Lindsay Mair

2. Richard Bucknell

3. Clive Milner

4. Rebecca Leigh

2

Reason for the notification

a)

Position/status

1. Non-executive Chairman

2. Chief Investment Officer

3. Operations Manager

4. Investment Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Macaulay Capital plc

b)

LEI

213800ZJXFVLJQC7OV11

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10 pence each

ISIN: GB00BNKBMF25

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

Price No. of options
1. £0

2. £0

3. £0

4. £0
1.  90,000

2. 460,000

3. 260,000

4. 190,000

d)

Aggregated information

- Aggregated volume

- Price

Volume: 1,000,000

Price: £0

e)

Date of the transaction

29 April 2024

f)

Place of the transaction

UK

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

ENDS 

Enquiries:

Macaulay Capital PLC
Clive Milner 44 (0)20 3946 5980
Cairn Financial Advisers LLP (AQSE Corporate Adviser)
Louise O'Driscoll +44 (0)20 7213 0880
Oberon Capital (Broker)
Chris Crawford +44 (0)20 3179 5304

For more information please visit:   www.macaulaycapital.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXGZGZDVVNGDZM

Talk to a Data Expert

Have a question? We'll get back to you promptly.